Question 1

How many institutions own CLYM stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CLYM shares is 94, representing 81.77% of the company's common stock.

Question 2

Who are the major shareholders selling Climb Bio, Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in CLYM by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the CLYM shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned CLYM shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying CLYM stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in CLYM by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of CLYM to its portfolio, raising its holding to - shares of worth -. N/A also increased its CLYM shares holding by N/A which brought its holding to - shares worth -.

Question 4

CLYM's major insiders: who are they?

Accepted Answer

The insider with the most stakes in CLYM is RA CAPITAL MANAGEMENT, L.P. ,  at the company. Additionally, CLYM stock is highly held by President and CEO Brennan Aoife and SVP, Finance & CAO Pimblett Emily among others.

Question 5

Did an insider recently sell CLYM stock?

Accepted Answer

Company executives, directors, and other insiders own 8.19% percent of Climb Bio, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which CLYM insiders have sold stock, totaling 20.62K shares. Insiders that have sold shares include BRENNAN AOIFE and PIMBLETT EMILY.

Question 6

Which insider recently purchased CLYM stock?

Accepted Answer

There have been 2 transaction(s) during the past 6-months in which Climb Bio, Inc. insiders have bought stock, totalling 314561 shares

Question 7

How much of CLYM does insiders own?

Accepted Answer

Around 6.74M Climb Bio, Inc. shares are held by insiders, which represents about 8.19% of CLYM stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

CLYM , RA CAPITAL MANAGEMENT, L.P. holds the largest portfolio of the company's shares. CLYM shares owned by RA total nearly 3.4 million.

Question 9

Which institution holds the most shares in CLYM?

Accepted Answer

N/A is the largest institutional owner in CLYM which holds - shares worth - or N/A of the total CLYM shares outstanding followed by N/A with ownership of - shares representing N/A of the CLYM ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Climb Bio, Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CLYM is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on CLYM's shares?

Accepted Answer

Number of CLYM shares short is 1.21M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding CLYM shares are there?

Accepted Answer

As of today, 67.76M shares of CLYM are outstanding.

Question 13

Is there many float in CLYM stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CLYM has 25.58M shares in float.

Question 14

CLYM short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CLYM is 1.58.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 12, 2025	RA CAPITAL MANAGEMENT, L.P.	PURCHASE	2.86	101.46K	290.18K	3.4M
Dec 11, 2025	RA CAPITAL MANAGEMENT, L.P.	PURCHASE	2.18	213.1K	464.56K	3.29M
Jun 30, 2025	BRENNAN AOIFE	SALE	1.22	20.62K	25.15K	48.13K
Jun 20, 2025	PIMBLETT EMILY	SALE	1.24	1.24K	1.54K	18.89K
Mar 20, 2025	PIMBLETT EMILY	SALE	1.31	1.2K	1.57K	15.13K
Dec 19, 2024	PIMBLETT EMILY	SALE	2.02	1.24K	2.49K	11.33K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 12, 2025	RA CAPITAL MANAGEMENT, L.P.	PURCHASE	2.86	101.46K	290.18K	3.4M
Dec 11, 2025	RA CAPITAL MANAGEMENT, L.P.	PURCHASE	2.18	213.1K	464.56K	3.29M
Jun 30, 2025	BRENNAN AOIFE	SALE	1.22	20.62K	25.15K	48.13K
Jun 20, 2025	PIMBLETT EMILY	SALE	1.24	1.24K	1.54K	18.89K
Mar 20, 2025	PIMBLETT EMILY	SALE	1.31	1.2K	1.57K	15.13K
Dec 19, 2024	PIMBLETT EMILY	SALE	2.02	1.24K	2.49K	11.33K

CLYM Stock Ownership Breakdown

Climb Bio

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions